Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenoc...
Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma
About this item
Full title
Author / Creator
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
The relevance of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC) is largely unknown. Clinical trials targeting ER with selective estrogen receptor modulators in pancreatic cancer did not show any benefit. Here, we analyze the impact of recently characterized ER isoform beta on survival in a cohort of patients with resec...
Alternative Titles
Full title
Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_30c54ab57a864b43922dd8ee2336fe9e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_30c54ab57a864b43922dd8ee2336fe9e
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-018-4973-6
